Target intelligence / Profile preview

Bile salt export pump (ABCB11) (BSEP)

Target
BSEP
Molecular classification
Transporter, ATP-binding cassette transporter
01

Overview

The Bile salt export pump (ABCB11), also known as BSEP, is the primary transport protein responsible for the secretion of bile acids from hepatocytes into the bile canaliculi. As a member of the ATP-binding cassette (ABC) transporter family, it utilizes ATP hydrolysis to move bile salts against a steep concentration gradient, which is the rate-limiting step in bile formation and essential for the enterohepatic circulation of bile acids (UniProt: O95342). Dysfunction of BSEP, whether through genetic mutations or drug-induced inhibition, leads to the accumulation of toxic bile acids within the liver, resulting in cholestasis and severe hepatocellular injury (PubMed: 10359813). Genetic defects in the ABCB11 gene cause Progressive Familial Intrahepatic Cholestasis type 2 (PFIC2), a condition often requiring liver transplantation in childhood. In drug development, BSEP is a critical safety target; many drugs associated with drug-induced liver injury (DILI), such as bosentan and troglitazone, are known to inhibit BSEP activity (PubMed: 12482951). Conversely, therapeutic strategies for cholestatic diseases often involve inducing BSEP expression through the activation of the Farnesoid X receptor (FXR), which serves as its primary transcriptional regulator (PubMed: 23714154). Note: The provided name 'Bile acid secretion' refers to a physiological process rather than a single molecular target, but BSEP is the canonical protein responsible for this function.

Other names
ABCB11ATP-binding cassette sub-family B member 11Sister of P-glycoproteinsPgpPGY11
02

Mechanism of action

Inhibition of ATP-dependent bile salt transport; Induction of protein expression via PXR/FXR activation.

03

Biological functions

Bile acid transportBile formationCholesterol homeostasisLipid metabolism
04

Disease associations

CholestasisProgressive familial intrahepatic cholestasis type 2Drug-induced liver injuryIntrahepatic cholestasis of pregnancyGallstones
05

Safety considerations

Drug-induced liver injury (DILI)Intrahepatic cholestasisHyperbilirubinemiaPruritus
06

Interacting drugs

Rifampicin

6 more in the full profile.

07

Biomarkers

Serum bile acid levelsTotal and direct bilirubinGamma-glutamyl transferase (GGT)

Beyond the preview

Go deeper on Bile salt export pump (ABCB11) (BSEP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bile salt export pump (ABCB11) (BSEP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call